| Piedmont Family Medicine, P.a. | |
|
1401 W Innes St Ste B Salisbury NC 28144-2575 | |
| (704) 636-5626 | |
| (704) 636-5641 |
| Full Name | Piedmont Family Medicine, P.a. |
|---|---|
| Speciality | Clinic/Center |
| Location | 1401 W Innes St Ste B, Salisbury, North Carolina |
| Authorized Official Name and Position | Chetan N Amin (OWNER) |
| Authorized Official Contact | 7046365626 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Piedmont Family Medicine, P.a. 1401 W Innes St Ste B Salisbury NC 28144-2575 Ph: (704) 636-5626 | Piedmont Family Medicine, P.a. 1401 W Innes St Ste B Salisbury NC 28144-2575 Ph: (704) 636-5626 |
| NPI Number | 1104968627 |
|---|---|
| Provider Enumeration Date | 02/12/2007 |
| Last Update Date | 06/03/2013 |
| Medicare PECOS PAC ID | 8426125816 |
|---|---|
| Medicare Enrollment ID | O20080926000556 |
News Archive
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of Hodgkin lymphoma (HL). The Company is currently investigating pralatrexate in a number of ongoing studies, including a Phase 2 clinical study in patients with relapsed or refractory non-Hodgkin lymphoma or Hodgkin lymphoma.
Researchers have identified a new mechanism that the tumor suppressor protein p53 uses to trigger cell death via apoptosis and have shown how the process could be harnessed to kill cancer cells. St. Jude Children's Research Hospital scientists led the study, which appears today in the scientific journal Molecular Cell.
The ABC Medical Center, located in Mexico City, implemented various molecular diagnostic methods that can detect the genetic alterations in several types of cancer, so they can select a personalized therapy for each patient and direct it against the mutated genes that cause disease.
CardioPharma is beginning the final funding phase before submitting an NDA for CardiaPill, the world's first patented triple-combination cardiovascular polypill. "The recent news from Kaiser Permanente reinforces that in this cost containment and efficacy oriented healthcare environment, CardiaPill is in the right place at the right time," stated Don Sellers, CardioPharma's Chairman and CEO.
Researchers found about 10% of blood monocytes in coronavirus disease 2019 (COVID-19) patients are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These monocytes then die, leading to the release of cytokines – a feature associated with severe and critical COVID-19.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104968627 | NPI | - | NPPES |
| 012MO | Other | NC | BCBS GROUP NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
| Provider Name | Chetan N Amin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1104892249 PECOS PAC ID: 0345317731 Enrollment ID: I20080926000544 |
News Archive
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of Hodgkin lymphoma (HL). The Company is currently investigating pralatrexate in a number of ongoing studies, including a Phase 2 clinical study in patients with relapsed or refractory non-Hodgkin lymphoma or Hodgkin lymphoma.
Researchers have identified a new mechanism that the tumor suppressor protein p53 uses to trigger cell death via apoptosis and have shown how the process could be harnessed to kill cancer cells. St. Jude Children's Research Hospital scientists led the study, which appears today in the scientific journal Molecular Cell.
The ABC Medical Center, located in Mexico City, implemented various molecular diagnostic methods that can detect the genetic alterations in several types of cancer, so they can select a personalized therapy for each patient and direct it against the mutated genes that cause disease.
CardioPharma is beginning the final funding phase before submitting an NDA for CardiaPill, the world's first patented triple-combination cardiovascular polypill. "The recent news from Kaiser Permanente reinforces that in this cost containment and efficacy oriented healthcare environment, CardiaPill is in the right place at the right time," stated Don Sellers, CardioPharma's Chairman and CEO.
Researchers found about 10% of blood monocytes in coronavirus disease 2019 (COVID-19) patients are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These monocytes then die, leading to the release of cytokines – a feature associated with severe and critical COVID-19.
› Verified 3 days ago
News Archive
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of Hodgkin lymphoma (HL). The Company is currently investigating pralatrexate in a number of ongoing studies, including a Phase 2 clinical study in patients with relapsed or refractory non-Hodgkin lymphoma or Hodgkin lymphoma.
Researchers have identified a new mechanism that the tumor suppressor protein p53 uses to trigger cell death via apoptosis and have shown how the process could be harnessed to kill cancer cells. St. Jude Children's Research Hospital scientists led the study, which appears today in the scientific journal Molecular Cell.
The ABC Medical Center, located in Mexico City, implemented various molecular diagnostic methods that can detect the genetic alterations in several types of cancer, so they can select a personalized therapy for each patient and direct it against the mutated genes that cause disease.
CardioPharma is beginning the final funding phase before submitting an NDA for CardiaPill, the world's first patented triple-combination cardiovascular polypill. "The recent news from Kaiser Permanente reinforces that in this cost containment and efficacy oriented healthcare environment, CardiaPill is in the right place at the right time," stated Don Sellers, CardioPharma's Chairman and CEO.
Researchers found about 10% of blood monocytes in coronavirus disease 2019 (COVID-19) patients are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These monocytes then die, leading to the release of cytokines – a feature associated with severe and critical COVID-19.
› Verified 3 days ago
Southpoint Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 340 Jake Alexander Blvd W, Salisbury, NC 28147 Phone: 704-403-6260 Fax: 704-403-6261 | |
Southeast Bariatrics Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 911 West Henderson Street, Kiser Building, Suite 410, Salisbury, NC 28144 Phone: 704-347-4144 Fax: 704-347-4148 | |
Copperfield Medical Center, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 611 Mocksville Ave, Salisbury, NC 28144 Phone: 704-633-7220 Fax: 704-647-0515 | |
Northeast Endocrinology-salisbury Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 340 Jake Alexander Blvd W, Suite C, Salisbury, NC 28147 Phone: 704-403-8320 Fax: 704-403-8321 | |
Novant Health Bariatric Solutions Rowan Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1910 Jake Alexander Blvd W Ste 201, Salisbury, NC 28147 Phone: 704-638-8631 Fax: 704-638-8639 | |
Novant Health Diabetes Management Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1904 Jake Alexander Blvd W Ste 301, Salisbury, NC 28147 Phone: 704-638-1555 | |
Novant Health Granite Quarry Internal Medicine & Pediatrics Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 S Salisbury Gq Ave, Salisbury, NC 28146 Phone: 704-279-1679 Fax: 704-279-1677 |